ProQR Therapeutics
PRQR
PRQR
42 hedge funds and large institutions have $134M invested in ProQR Therapeutics in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 18 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
24% less capital invested
Capital invested by funds: $177M → $134M (-$42.8M)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
39% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 18
Holders
42
Holding in Top 10
1
Calls
$8K
Puts
$3K
Top Buyers
| 1 | +$668K | |
| 2 | +$337K | |
| 3 | +$328K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$118K |
| 5 |
Mirae Asset Global Investments
Seoul,
South Korea
|
+$60.9K |
Top Sellers
| 1 | -$2.75M | |
| 2 | -$1.7M | |
| 3 | -$838K | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$700K |
| 5 |
ACM
Aquilo Capital Management
San Francisco,
California
|
-$573K |